Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
Merck Sharp & Dohme Corp.
C C A C A C C A
C07D C07D A61P C07F A61P C07F C07D A61P
inventional inventional inventional inventional inventional inventional inventional inventional
Guoqing Wensheng Qinglin Yongqi Joseph Hongjun Kun Liangqin Purakkattle Timothy A. Zhi-Cai Yongxin Xavier Derun Shuwen Abdelghani
Li Yu Pu Deng Kozlowski Zhang Liu Guo Biju Cernak Shi Han Fradera Li He Achab